Asthma Drug Developer To Wind Down In Chancery Court
A subsidiary of Rock Creek Advisors LLC created to administer the liquidation of an asthma drug developer to pay creditors notified Delaware's chancery court that the company turned to a wind-down...To view the full article, register now.
Already a subscriber? Click here to view full article